ロード中...
Adenosine receptor activation ameliorates type 1 diabetes
Growing evidence indicates that adenosine receptors could be promising therapeutic targets in autoimmune diseases. Here we studied the role of adenosine receptors in controlling the course of type 1 diabetes. Diabetes in CD-1 mice was induced by multiple-low-dose-streptozotocin (MLDS) treatment and...
保存先:
| 主要な著者: | , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2007
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2225539/ https://ncbi.nlm.nih.gov/pubmed/17405852 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1096/fj.07-8213com |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|